Kiran Turaga

Kiran Turaga, MD, MPH, is a Professor of Surgery (Oncology) and Division Chief of Surgical Oncology at Yale School of Medicine. He also serves as Assistant Medical Director of the Clinical Trials Office at Yale Cancer Center. His expertise includes advanced surgical treatments for gastrointestinal cancers, peritoneal mesothelioma, and metastatic soft tissue cancers. Dr. Turaga is renowned for his work with hyperthermic intraperitoneal chemotherapy (HIPEC) and oligometastatic cancer management. He leads clinical trials exploring immunotherapy and liquid biopsy in cancer surgery.

Education:

• MD: All India Institute of Medical Sciences
• MPH: Johns Hopkins University

Research: Focuses on novel diagnostics/therapeutics for oligometastatic cancer, big data optimization for patient care, and surgical innovations. His work bridges immunotherapy, liquid biopsy, and surgical outcomes.

Grants & Trials: Principal Investigator on clinical trials investigating HIPEC, immunotherapy, and liquid biopsy applications. Active in translational research and global cancer surgery initiatives.

Labs/Teams: Leads the Surgical Oncology division at Yale Cancer Center, collaborating with multidisciplinary teams on HIPEC and regional therapies. Engaged in global cancer surgery advocacy.